Lesley Calhoun
Net worth: 173 316 $ as of 2026-08-30
Net worth: 173 316 $ as of 2026-08-30
Lesley Ann Calhoun is currently Director at Tango Therapeutics Sub, Inc. since 2021, Independent Director at Tango Therapeutics, Inc. since 2021, Treasurer at California Life Sciences Association, and Executive VP, Chief Operating & Financial Officer at Aligos Therapeutics, Inc. since 2020.
Former roles include Senior Director-Finance & Controller at Innoviva, Inc. from 2005 to 2013, Vice President-Finance at Hyperion Therapeutics, Inc. from 2013 to 2015, Chief Accounting Officer & SVP-Administration at Global Blood Therapeutics, Inc. from 2016 to 2020, and Member at Deloitte & Touche LLP from 1989 to 2001.
Education includes undergraduate studies at San Francisco State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-04 | 6,250 ( 0.01% ) | 142 750 $ | 2026-08-30 | |
| 2026-03-30 | 5,216 ( 0.1% ) | 30 566 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Director of Finance/CFO | 2020-05-31 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | 2021-02-28 |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Director/Board Member | 2021-03-23 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Administrative Officer | 2020-05-31 |
| HYPERION THERAPEUTICS INC | Corporate Officer/Principal | 2015-08-31 |
| INNOVIVA, INC. | Director of Finance/CFO | 2012-12-31 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 2000-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions